Table 2.

Patient Outcome

Patient No.	Diagnosis	Disease at T-Cell Infusion	T-Cell Dose	Outcome	Overall Survival (days)
1	OS	Right hip, multiple bones	1 × 104/m2	PD	1,109*
2	OS	Sacrum	1 × 104/m2	NE	34
3	OS	Right hip, lung	1 × 104/m2	PD	584
4	OS	Lung	3 × 104/m2	PD; surgery/salvage chemotherapy for PD; second infusion (1 × 105/m2); PR for 9 months	874
5	OS	Lung	3 × 104/m2	PD; second infusion (1 × 105/m2); PD	310
6	OS	Lung	1 × 105/m2	PD	107
7	OS	Lung	1 × 105/m2	PD; second infusion (1 × 105/m2); PD	303
8	OS	Pelvis, spine, lung	1 × 106/m2	PD	120
9	OS	Lung	1 × 106/m2	PD	151
10	PNET	Sacrum	3 × 106/m2	PD; tumor removed (no necrosis)	451
11	OS	Lung/pleura	3 × 106/m2	SD for 15 weeks; tumor removed (no necrosis); remains in remission	584*
12	DSCRT	Liver	1 × 107/m2	8 additional infusions; SD for 14 months	528*
13	OS	Lung	1 × 107/m2	PD	268
14	OS	Lung/pleura	3 × 107/m2	Second infusion; SD for 12 weeks; tumor removed (≥ 90% necrosis); 2 additional infusions; remains in remission	446*
15	OS	Bone, chest wall, brain, spine, marrow	3 × 107/m2	PD	156
16	OS	Pleura, liver, subdiaphragmatic	1 × 108/m2	NE	389*
17	ES	Lung	1 × 108/m2	PD	153
18	OS	Left femur	1 × 108/m2	Second infusion; SD for 12 weeks; tumor removed (no necrosis); remains in remission	290*
19	OS	Lung and bone	1 × 108/m2	PD	164

Abbreviations: DSRCT, desmoplastic small round cell tumor; ES, Ewing sarcoma; NE, not evaluable; OS, osteosarcoma; PD, progressive disease; PR, partial response; PNET, primitive neuroectodermal tumor; SD, stable disease.

^*Patient still alive.